The drug-resistance mechanisms of five platinum-based antitumor agents

J Zhou, Y Kang, L Chen, H Wang, J Liu… - Frontiers in …, 2020 - frontiersin.org
Platinum-based anticancer drugs, including cisplatin, carboplatin, oxaliplatin, nedaplatin,
and lobaplatin, are heavily applied in chemotherapy regimens. However, the intrinsic or …

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

A Shea, V Harish, Z Afzal, J Chijioke, H Kedir… - Cancer …, 2016 - Wiley Online Library
Glioblastoma multiforme (GBM) is the most common and lethal cancer of the adult brain,
remaining incurable with a median survival time of only 15 months. In an effort to identify …

Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance

M Shahlaei, SM Asl, A Derakhshani, L Kurek… - Journal of Molecular …, 2024 - Elsevier
Platinum-based drugs have maintained their preeminent position in cancer treatment
regimens even four decades after the approval of cisplatin. Although these agents have …

MicroRNA in glioblastoma: an overview

B Banelli, A Forlani, G Allemanni… - … journal of genomics, 2017 - Wiley Online Library
Glioblastoma is the most aggressive brain tumor and, even with the current multimodal
therapy, is an invariably lethal cancer with a life expectancy that depends on the tumor …

The network of non-coding RNAs in cancer drug resistance

F Corrà, C Agnoletto, L Minotti, F Baldassari… - Frontiers in …, 2018 - frontiersin.org
Non-coding RNAs (ncRNAs) have been implicated in most cellular functions. The disruption
of their function through somatic mutations, genomic imprinting, transcriptional and post …

Influence of microRNAs and long non-coding RNAs in cancer chemoresistance

D Ayers, J Vandesompele - Genes, 2017 - mdpi.com
Innate and acquired chemoresistance exhibited by most tumours exposed to conventional
chemotherapeutic agents account for the majority of relapse cases in cancer patients. Such …

Exosomal noncoding RNAs: key players in glioblastoma drug resistance

A Movahedpour, SH Khatami, M Khorsand… - Molecular and Cellular …, 2021 - Springer
Glioma, as one of the most severe human malignancies, is defined as the Central Nervous
System's (CNS) tumors. Glioblastoma (GBM) in this regard, is the most malignant type of …

MicroRNA in brain pathology: Neurodegeneration the other side of the brain cancer

J Godlewski, J Lenart, E Salinska - Non-coding RNA, 2019 - mdpi.com
The mammalian brain is made up of billions of neurons and supporting cells (glial cells),
intricately connected. Molecular perturbations often lead to neurodegeneration by …

Potential epigenetic-based therapeutic targets for glioma

L Zang, SM Kondengaden, F Che, L Wang… - Frontiers in Molecular …, 2018 - frontiersin.org
Glioma is characterized by a high recurrence rate, short survival times, high rates of mortality
and treatment difficulties. Surgery, chemotherapy and radiation (RT) are the standard …

LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin

M Taheri, H Shoorei, FT Anamag… - Experimental and …, 2021 - Elsevier
Cisplatin is an extensively used chemotherapeutic substance for various types of human
malignancies including sarcomas, carcinomas and lymphomas. Yet, the vast application of …